BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mercado CE, Hartsell WF, Simone CB 2nd, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries. Acta Oncol 2019;58:1036-40. [PMID: 30784340 DOI: 10.1080/0284186X.2019.1575981] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Loap P, Vitolo V, Barcellini A, De Marzi L, Mirandola A, Fiore MR, Vischioni B, Jereczek-Fossa BA, Girard N, Kirova Y, Orlandi E. Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice. Front Oncol 2021;11:738320. [PMID: 34707989 DOI: 10.3389/fonc.2021.738320] [Reference Citation Analysis]
2 McGunigal M, Margolis M, Forsthoefel M, Singh T, Amarell K, Deblois D, Campbell L, Kim C, Liu S, Bergquist PJ, Debrito P, Collins BT, Giaccone G, Lischalk JW. Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience. Acta Oncol 2021;60:649-52. [PMID: 33629926 DOI: 10.1080/0284186X.2021.1887516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Angrisani A, Houben R, Marcuse F, Hochstenbag M, Maessen J, De Ruysscher D, Peeters S. “Radiotherapy for Thymic Epithelial Tumors: What Is The Optimal Dose? A Systematic Review.”. Clinical and Translational Radiation Oncology 2022. [DOI: 10.1016/j.ctro.2022.03.005] [Reference Citation Analysis]
4 Loap P, Scher N, Goudjil F, Kirova Y, Girard N, Cao KI. Proton Beam Therapy for Thymic Carcinoma with Pericardial Involvement. Int J Part Ther 2021;7:65-70. [PMID: 33604417 DOI: 10.14338/IJPT-20-00023.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]